Survey: Providers dissatisfied with EHRs but planning HIT investments

Providers nationwide expect increased investments in health IT and telecommunications solutions and modern clinical equipment, according to a new survey from payer Premier, a Charlotte, N.C.-based firm dedicated to transforming the healthcare system.

The survey also suggests that 41 percent of respondents are dissatisfied or indifferent about their current EHR systems. “What we are hearing increasingly from healthcare leaders is dissatisfaction with their existing EHR systems, often citing cost and difficulty of use,” said Premier's COO Michael J. Alkire in a release. “Providers need a solution that integrates clinical, financial and operational data across their hospitals and health systems; the majority of EHR systems cannot do that.”

According to the spring 2014 Economic Outlook C-suite survey, 49 percent of the C-suite respondents plan to make their largest capital investments over the next year in health IT, including EHRs, advanced data analytics and telecommunications. These results are similar to last year's responses, up from 46 percent in spring 2013 and 45 percent from spring 2012. Twenty-two percent of respondents named acquisition of clinical equipment the area in which they are planning the largest capital investments, up from 12 percent in spring 2013.

While labor is considered the biggest driver of healthcare costs, cited by 42 percent of executives compared to 24 percent six months ago, 34 percent of survey respondents cited healthcare legislation and mandates. Since polling in fall 2013, the number of respondents who cited health IT as the biggest driver of costs jumped from 17 percent to 27 percent.

The majority (75 percent) of providers said they are experiencing physician or nurse shortages, with 42 percent experiencing shortages in more than one practice area.

Premier surveyed 127 C-suite executives, including CEOs, CFOs and COOs, from 112 hospitals and health systems of various sizes and types across 32 states.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.